(Q34361481)

1 August 2017

1 reference

title

Clinical trials of adenoviral-mediated suicide gene therapy of malignant gliomas (English)

1 reference

1 August 2017

0 references

0 references

1 reference

Nanda D

1

1 reference

PubMed ID

11545029

1 August 2017

Driesse MJ

series ordinal

2

1 reference

PubMed ID

11545029

1 August 2017

Sillevis Smitt PA

series ordinal

3

1 reference

1 August 2017

1 January 2001

1 reference

Progress in Brain Research

1 August 2017

1 reference

1 August 2017

132

1 reference

1 August 2017

699-710

1 reference

Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Survival and functional status after resection of recurrent glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Reports of adenovector "death" are greatly exaggerated

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Targeted gene delivery by tropism-modified adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

A system for the propagation of adenoviral vectors with genetically modified receptor specificities

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Intracerebral injection of adenovirus harboring the HSVtk gene combined with ganciclovir administration: toxicity study in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Intra-CSF administered recombinant adenovirus causes an immune response-mediated toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Irinotecan therapy in adults with recurrent or progressive malignant glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: pathologic, radiologic, and molecular studies

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Reoperation for recurrent glioblastoma and anaplastic astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Efficacy of a replication-competent adenovirus (ONYX-015) following intratumoral injection: intratumoral spread and distribution effects

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

A Phase I/II Study of Herpes Simplex Virus Type 1 Thymidine Kinase “Suicide” Gene Therapy for Recurrent Glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

The human TRIDENT/HFH-11/FKHL16 gene: structure, localization, and promoter characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Virus treatment questioned after gene therapy death

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Neurotoxicity of intracerebral injection of a replication-defective adenoviral vector in a semipermissive species (cotton rat).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Intracranial administration of adenovirus expressing HSV-TK in combination with ganciclovir produces a dose-dependent, self-limiting inflammatory response.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Studies on the use of viruses in the treatment of carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Brain tumor survival: results from the National Cancer Data Base

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

The bystander effect in the HSVtk/ganciclovir system and its relationship to gap junctional communication

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Expression of heterologous sequences in adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2801%2932111-8

7 January 2021

10.1016/S0079-6123(01)32111-8

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11545029